Effect of potassium-enriched salt on cardiovascular mortality and medical expenses of elderly men
BACKGROUND:The beneficial effects of potassium-enriched salt on blood pressure have been reported in a few short-term trials. The long-term effects of potassium-enriched salt on cardiovascular mortality have not been carefully studied. OBJECTIVE:The objective was to examine the effects of potassium-...
Gespeichert in:
Veröffentlicht in: | The American journal of clinical nutrition 2006-06, Vol.83 (6), p.1289-1296 |
---|---|
Hauptverfasser: | , , , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Zusammenfassung: | BACKGROUND:The beneficial effects of potassium-enriched salt on blood pressure have been reported in a few short-term trials. The long-term effects of potassium-enriched salt on cardiovascular mortality have not been carefully studied. OBJECTIVE:The objective was to examine the effects of potassium-enriched salt on cardiovascular disease (CVD) mortality and medical expenditures in elderly veterans. DESIGN:Five kitchens of a veteran retirement home were randomized into 2 groups (experimental or control) and veterans assigned to those kitchens were given either potassium-enriched salt (experimental group) or regular salt (control group) for [almost equal to]31 mo. Information on death, health insurance claims, and dates that veterans moved in or out of the home was gathered. RESULTS:Altogether, 1981 veterans, 768 in the experimental [x (±SD) age: 74.8 ± 7.1 y] and 1213 in the control (age: 74.9 ± 6.7 y) groups, were included in the analysis. The experimental group had better CVD survivorship than did the control group. The incidence of CVD-related deaths was 13.1 per 1000 persons (27 deaths in 2057 person-years) and 20.5 per 1000 (66 deaths in 3218 person-years) for the experimental and control groups, respectively. A significant reduction in CVD mortality (age-adjusted hazard ratio: 0.59; 95% CI: 0.37, 0.95) was observed in the experimental group. Persons in the experimental group lived 0.3-0.90 y longer and spent significantly less ([almost equal to]US $426/y) in inpatient care for CVD than did the control group, after control for age and previous hospitalization expenditures. CONCLUSIONS:This study showed a long-term beneficial effect on CVD mortality and medical expenditure associated with a switch from regular salt to potassium-enriched salt in a group of elderly veterans. The effect was likely due to a major increase in potassium and a moderate reduction in sodium intakes. |
---|---|
ISSN: | 0002-9165 1938-3207 |
DOI: | 10.1093/ajcn/83.6.1289 |